Big Leap Clinical Research Joint Stock Company   Report issue

For profit Phase 2 Phase 3
Founded: Ho Chi Minh City Vietnam (2010)

Organization Overview

First Clinical Trial
2017
NCT03845959
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Big Leap Clinical Research Joint Stock Company | Big Leap Clinical Research Support Joint Stock Company